# Comparison of Prasugrel and Clopidogrel in Very Elderly and Non-Elderly Patients With Stable Coronary Artery Disease

> **NCT01107912** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 155 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** prasugrel
- **DRUG:** clopidogrel

## Key facts

- **NCT ID:** NCT01107912
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 155 (ACTUAL)
- **Last updated:** 2012-10-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01107912

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01107912, "Comparison of Prasugrel and Clopidogrel in Very Elderly and Non-Elderly Patients With Stable Coronary Artery Disease". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01107912. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*